Table 4 Event-free survival EFS and overall survival OS and their relation to the prognostic factors
From: Localized Wilms’ tumor in low-middle-income countries (LMIC): how can we get better?
No. | No. of events | 5-year EFS (%) | p value | No. of deaths | 5-year OS (%) | p value | |
|---|---|---|---|---|---|---|---|
Whole group | 92 | 15 | 83.7% | 5 | 94.6% | ||
Gender | |||||||
Male | 62 | 13 | 79.0% | 4 | 93.5% | ||
Female | 30 | 2 | 93.3% | 0.089 | 1 | 96.6% | 0.575 |
Age groups | |||||||
< 2 years | 25 | 4 | 84.0% | 0 | 100% | ||
> = 2 years | 67 | 11 | 83.6% | 0.949 | 5 | 92.5% | 0.148 |
Nephrectomy | |||||||
Upfront | 63 | 12 | 81.0% | 2 | 96.8% | ||
Delayed | 29 | 3 | 89.7% | 0.337 | 3 | 89.7% | 0.139 |
LN sampling | |||||||
Yes | 49 | 9 | 81.6% | 3 | 93.9% | ||
No | 43 | 6 | 86.0% | 0.589 | 2 | 95.3% | 0.796 |
Stage | |||||||
Stage I and II | 46 | 8 | 82.6% | 0 | 100% | ||
Stage III | 46 | 7 | 84.8% | 0.788 | 5 | 89.1% | 0.024 |
Histology | |||||||
Favorable (including nuclear unrest) | 84 | 12 | 85.7% | 3 | 96.4% | ||
Unfavorable | 8 | 3 | 62.5% | 0.073 | 2 | 75.0% | 0.009 |
Histology | |||||||
Favorable | 80 | 9 | 88.8% | 3 | 96.3% | ||
Unfavorable (including nuclear unrest) | 12 | 6 | 50.0% | < 0.001 | 2 | 83.3% | 0.043 |
Stage and histology (favorable including nuclear unrest) | |||||||
Stage I/II favorable | 44 | 8 | 81.8% | 0 | 100% | ||
Stage III favorable | 40 | 4 | 90.0% | 0.304 | 3 | 92.5% | 0.063 |
Stage I/II unfavorable | 2 | 0 | 100% | 0 | 100% | ||
Stage III unfavorable | 6 | 3 | 50% | * | 2 | 66.7% | * |
Stage and histology (unfavorable including nuclear unrest) | |||||||
Stage I/II favorable | 41 | 5 | 87.8% | 0 | 100% | ||
Stage III favorable | 39 | 4 | 89.7% | 0.791 | 3 | 92.3% | 0.065 |
Stage I/II unfavorable | 5 | 3 | 40.0% | 0 | 100% | ||
Stage III unfavorable | 7 | 3 | 57.1% | 0.563 | 2 | 71.4% | 0.345 |